-transparent.png){kind=logo}
We report a case of a female patient with chronic myelogenous leukemia who presented, 8 yr after initial diagnosis, with pancytopenia, encephalopathy, and myalgia. The tentative diagnosis was accelerated phase of chronic myelogenous leukemia. However, because the patient had been treated with cimetidine for 7 months we first omitted this drug. When cimetidine was stopped, bone marrow recovered, and myalgia and encephalopathy subsided. Immunological studies showed stimulation of the patient's lymphocyte blastogenesis by cimetidine and a marked increase in the proportion of cytotoxic/suppressor T lymphocytes after incubation of peripheral blood lymphocytes with cimetidine for 6 days. These findings indicate a role for cell-mediated immunity in the pathogenesis of cimetidine-induced pancytopenia in this patient.
A Nagler, and
H Rozenbaum, and
R Enat, and
I Tatarsky, and
R Katz, and
S Pollack
February 1979,
Annals of internal medicine,
A Nagler, and
H Rozenbaum, and
R Enat, and
I Tatarsky, and
R Katz, and
S Pollack
May 2005,
Transfusion,
A Nagler, and
H Rozenbaum, and
R Enat, and
I Tatarsky, and
R Katz, and
S Pollack
May 1979,
Annals of internal medicine,
A Nagler, and
H Rozenbaum, and
R Enat, and
I Tatarsky, and
R Katz, and
S Pollack
February 1994,
The American journal of gastroenterology,
A Nagler, and
H Rozenbaum, and
R Enat, and
I Tatarsky, and
R Katz, and
S Pollack
June 1990,
Blut,
A Nagler, and
H Rozenbaum, and
R Enat, and
I Tatarsky, and
R Katz, and
S Pollack
May 1956,
Klinische Wochenschrift,
A Nagler, and
H Rozenbaum, and
R Enat, and
I Tatarsky, and
R Katz, and
S Pollack
September 1979,
British journal of haematology,
A Nagler, and
H Rozenbaum, and
R Enat, and
I Tatarsky, and
R Katz, and
S Pollack
October 1982,
Southern medical journal,
A Nagler, and
H Rozenbaum, and
R Enat, and
I Tatarsky, and
R Katz, and
S Pollack
July 2010,
Transfusion,
A Nagler, and
H Rozenbaum, and
R Enat, and
I Tatarsky, and
R Katz, and
S Pollack
October 1979,
La Nouvelle presse medicale,
